In the News

413 News Items found
Close up of gloved hands working in a lab
MSK Research Highlights September 29, 2023
New research from MSK develops a method for analyzing cancer cells that survive treatment for acute myeloid leukemia; identifies a transcription factor that orchestrates natural killer cell response; and finds vepafestinib is a promising therapeutic for the treatment of RET-driven cancers.
A researcher working in an MSK lab
MSK Research Highlights, April 23, 2025
New MSK research identifies a rare cell population responsible for AML persistence and resistance to therapy; sheds new light on early brain development; and investigates how other health conditions can increase cancer risk in midlife. MSK clinical trials also supported the recent approval of the targeted drug larotrectinib by the FDA.
Perry Ortiz surrounded by his wife, daughter, and two sons
Perry Ortiz doesn’t remember having a seizure in 2016. Or being rushed to an operating room, where doctors confirmed Perry — a security supervisor at M...
GSK Dean Michael Overholtzer stands at the podium
Event
Memorial Sloan Kettering’s 42nd annual ceremony recognized graduates and award winners with a virtual ceremony.
A lab coat with an MSK logo hangs on a hook
Fourteen young scientists are poised to receive their PhD degrees from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences. Their years of dedication and training will be recognized on May 14, 2025, as part of Memorial Sloan Kettering’s 46th annual academic convocation.
Scientists Jan Remsik, Adrienne Boire, and Jessica Wilcox in the lab
Finding
The presence of inflammatory molecules in the cerebrospinal fluid appears to be causing many of the neurologic effects seen in people with COVID-19.
Medical oncologist Bill Tap examines a patient
Feature
Spend a day with the expert team in MSK's world-renowned sarcoma service.
A researcher working in an MSK lab
MSK Research Highlights, March 26, 2025
New MSK research develops a new tool for studying mitochondrial DNA deletions; uncovers mechanisms of histiocytosis-associated neurodegeneration; and investigates how mutant stem cells co-opt regeneration to make tumors grow.
Linde Miles
Q&A
Dr. Miles is a postdoctoral fellow in the Human Oncology and Pathogenesis Program at MSK studying the genetics of blood cancers.
Imre Jeszek sits in front of a tent on a mountain
Experts at MSK recommend thinking carefully about the potential risks and benefits of elective whole-body MRI scans, especially if they’re done at standalone facilities and without a specific medical reason.